Academic Patents and Access to Medicines in Developing Countries
- 1 January 2009
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 99 (1), 9-17
- https://doi.org/10.2105/ajph.2007.128769
Abstract
There is a widespread and growing concern that patents hinder access to life-saving drugs in developing countries. Recent student movements and legislative initiatives emphasize the potential role that research universities in developed countries could have in ameliorating this “access gap.” These efforts are based on the assumption that universities own patents on a substantial number of drugs and that patents on these drugs are currently filed in developing countries. I provide empirical evidence regarding these issues and explore the feasibility and desirability of proposals to change university patenting and licensing practices to promote access to medicines in the developing world.Keywords
This publication has 7 references indexed in Scilit:
- The Anatomy of Medical School PatentingThe New England Journal of Medicine, 2007
- Leveraging University Research to Advance Global HealthJAMA, 2007
- Global framework on essential health R&DThe Lancet, 2006
- Improving Access to Medicines in Poor Countries: The Role of UniversitiesPLoS Medicine, 2006
- Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?JAMA, 2001
- Public–private interaction in pharmaceutical researchProceedings of the National Academy of Sciences of the United States of America, 1996
- Global burden of the HIV pandemicThe Lancet, 1996